0001727477-19-000008.txt : 20190514
0001727477-19-000008.hdr.sgml : 20190514
20190514174126
ACCESSION NUMBER: 0001727477-19-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190514
FILED AS OF DATE: 20190514
DATE AS OF CHANGE: 20190514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Voigtlander Christian B.
CENTRAL INDEX KEY: 0001727477
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 19824130
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2019-05-14
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001727477
Voigtlander Christian B.
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
Chief Operating Officer
Common Stock
2019-05-14
4
S
0
4448
227.49
D
4732
D
Common Stock
2019-05-14
4
S
0
900
228.07
D
3832
D
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $226.88 to $227.86, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $227.93 to $228.40, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
By: Alejandro Parras, Attorney-In-Fact For: Christian B. Voigtlander
2019-05-14